Transactions
19
Insider / TENET HEALTHCARE CORP
Sutaria Saumya
CEO at TENET HEALTHCARE CORP
- Company
- TENET HEALTHCARE CORP
- Ticker
- THC
- First filing on record
- January 2, 2026
- Latest trade on record
- August 25, 2026
- SEC filings
- EDGAR ↗
Sutaria Saumya, CEO at TENET HEALTHCARE CORP, has disclosed 19 transactions in THC since January 2, 2026: 0 purchases (0 open-market buys) and 9 sales, worth about $68.2M at the reported prices. The latest was filed August 26, 2026, 1 day after the trade.
Open-market buys
0
Sales
9
Avg. disclosure lag
2.8d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Sutaria Saumya made no purchases and 9 sales worth $68M, plus 10 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Sutaria Saumya has traded 1 stock on record; the largest by dollars is THC.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 5 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 8 | 180,118 | — |
| S | Open-market sale | 5 | 100,000 | $27.6M |
| F | Shares withheld for tax | 4 | 170,770 | $40.6M |
| A | Grant or award | 2 | 281,684 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 16 | 0 | 8 · $66.9M |
| 2025 | 3 | 0 | 1 · $1.3M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| THC | Sell S | August 25, 2026 | August 26, 2026 | 1d | 7,899 | $275 | $2.2M | Form 4 ↗ | ||
| THC | Sell S | August 25, 2026 | August 26, 2026 | 1d | 24,881 | $274 | $6.8M | Form 4 ↗ | ||
| THC | Sell S | August 25, 2026 | August 26, 2026 | 1d | 17,220 | $273 | $4.7M | Form 4 ↗ | ||
| THC | Sell S | August 24, 2026 | August 26, 2026 | 2d | 36,656 | $279 | $10.2M | Form 4 ↗ | ||
| THC | Sell S | August 24, 2026 | August 26, 2026 | 2d | 13,344 | $278 | $3.7M | Form 4 ↗ | ||
| THC | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 36,384 | — | — | derivative | Form 4 ↗ | |
| THC | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 22,417 | — | — | derivative | Form 4 ↗ | |
| THC | Other A | February 27, 2026 | March 3, 2026 | 4d | 36,092 | — | — | derivative | Form 4 ↗ | |
| THC | Sell F | February 27, 2026 | March 3, 2026 | 4d | 124,959 | $239 | $29.9M | Form 4 ↗ | ||
| THC | Sell F | February 27, 2026 | March 3, 2026 | 4d | 29,919 | $239 | $7.2M | Form 4 ↗ | ||
| THC | Sell F | February 27, 2026 | March 3, 2026 | 4d | 9,282 | $238 | $2.2M | Form 4 ↗ | ||
| THC | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 36,384 | — | — | Form 4 ↗ | ||
| THC | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 22,417 | — | — | Form 4 ↗ | ||
| THC | Option / conversion M | February 24, 2026 | February 26, 2026 | 2d | 18,242 | — | — | derivative | Form 4 ↗ | |
| THC | Option / conversion M | February 24, 2026 | February 26, 2026 | 2d | 18,242 | — | — | Form 4 ↗ | ||
| THC | Other A | February 13, 2026 | February 17, 2026 | 4d | 245,592 | — | — | Form 4 ↗ | ||
| THC | Option / conversion M | December 31, 2025 | January 2, 2026 | 2d | 13,016 | — | — | derivative | Form 4 ↗ | |
| THC | Sell F | December 31, 2025 | January 2, 2026 | 2d | 6,610 | $199 | $1.3M | Form 4 ↗ | ||
| THC | Option / conversion M | December 31, 2025 | January 2, 2026 | 2d | 13,016 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| August 26, 2026 | Form 4 | 0001193125-26-369162 | 5 | published | EDGAR ↗ |
| March 3, 2026 | Form 4 | 0001193125-26-089422 | 8 | published | EDGAR ↗ |
| February 26, 2026 | Form 4 | 0001193125-26-078289 | 2 | published | EDGAR ↗ |
| February 17, 2026 | Form 4 | 0001193125-26-055526 | 1 | published | EDGAR ↗ |
| January 2, 2026 | Form 4 | 0001193125-26-001194 | 3 | published | EDGAR ↗ |
Other insiders at TENET HEALTHCARE CORP
- Fitzgerald Meghan Director 18 rows
- Arbour Paola M Director 16 rows
- Ramsey R. Scott Principal Accounting Officer 16 rows
- Arnst Thomas W EVP, Chief Admin. Officer & GC 14 rows
- Foo Lisa Y EVP, Chief Operating Officer 13 rows
- HANEY CECIL D Director 13 rows
- KERREY J ROBERT Director 13 rows
- West Nadja Director 13 rows
- MARK RICHARD J Director 12 rows
- Romo Tammy Director 12 rows
Everyone on file, with contracts and lobbying under the company's name: TENET HEALTHCARE CORP.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 5 | 19 | January 2, 2026 | August 26, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.